The effectiveness of etanercept and adalimumab on anemia of chronic disease and serum hepcidin in patients with rheumatoid arthritis, a comparative study

ConclusionsTreatment with etanercept or adalimumab plus MTX significantly improved ACD in RA patients without significant differences between them. Serum hepcidin is a potential indicator for anemia of chronic disease and disease activity in RA patients.
Source: The Egyptian Rheumatologist - Category: Rheumatology Source Type: research